Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 10, 2022 Filed Feb 15, 2022 01:03 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 254 | $29.38 | $7,462.52 |
DisclosureSEC source: 0001437749-22-003346 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,893 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:02 UTC |
Aebersold SarahVP, Global Human Resources
|
SaleCommon Stock | 197 | $29.38 | $5,787.86 |
DisclosureSEC source: 0001437749-22-003345 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,039 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:02 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 293 | $29.38 | $8,608.34 |
DisclosureSEC source: 0001437749-22-003344 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,527 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:02 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 690 | $29.38 | $20,272.20 |
DisclosureSEC source: 0001437749-22-003343 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,765 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 10, 2022 Filed Feb 15, 2022 01:01 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 450 | $29.38 | $13,221.00 |
DisclosureSEC source: 0001437749-22-003342 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,564 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| February 03, 2022 Filed Feb 5, 2022 01:12 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 9,837 | $0.00 Strike: $2.06 | $0.00 |
DisclosureSEC source: 0001437749-22-002543 · rdgdoc.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 9,837 shares Expires 2025-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On May 4, 2015, the reporting person was granted an option to purchase 229,837 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2022 Filed Feb 5, 2022 01:12 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 9,837 | $27.76 | $273,075.12 |
DisclosureSEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.34 to $28.44, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 03, 2022 Filed Feb 5, 2022 01:12 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 9,837 | $2.06 | $20,264.22 |
DisclosureSEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2022 Filed Feb 8, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 16,670 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001437749-22-002647 · rdgdoc.xml · derivative · entry 3 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,670 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2022 Filed Feb 8, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 16,670 | $27.84 | $464,092.80 |
DisclosureSEC source: 0001437749-22-002647 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.35 to $28.43, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 03, 2022 Filed Feb 8, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 16,670 | $1.78 | $29,672.60 |
DisclosureSEC source: 0001437749-22-002647 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2022 Filed Feb 5, 2022 01:12 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $3.70 | $0.00 |
DisclosureSEC source: 0001437749-22-002543 · rdgdoc.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-04-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On April 21, 2014, the reporting person was granted an option to purchase 10,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| February 02, 2022 Filed Feb 5, 2022 01:12 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $29.88 | $298,800.00 |
DisclosureSEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.49 to $30.48, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 02, 2022 Filed Feb 5, 2022 01:12 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $3.70 | $37,000.00 |
DisclosureSEC source: 0001437749-22-002543 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 02:31 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 16,666 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001437749-22-002428 · rdgdoc.xml · derivative · entry 3 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,670 Underlying: Common Stock · 16,666 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 02:31 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 16,666 | $29.90 | $498,313.40 |
DisclosureSEC source: 0001437749-22-002428 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.31 to $30.54, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 01, 2022 Filed Feb 4, 2022 02:31 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 16,666 | $1.78 | $29,665.48 |
DisclosureSEC source: 0001437749-22-002428 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2022 Filed Jan 25, 2022 02:07 UTC |
Aebersold SarahVP, Global Human Resources
|
SaleCommon Stock | 332 | $30.24 | $10,039.68 |
DisclosureSEC source: 0001437749-22-001524 · rdgdoc.xml · nonDerivative · entry 1 Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,236 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 20, 2022 Filed Jan 25, 2022 02:07 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 395 | $30.24 | $11,944.80 |
DisclosureSEC source: 0001437749-22-001523 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,391 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 16,666 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001437749-22-000824 · rdgdoc.xml · derivative · entry 6 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,336 Underlying: Common Stock · 16,666 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 16,666 | $31.72 | $528,645.52 |
DisclosureSEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 4 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.17 to $32.19, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 16,666 | $1.78 | $29,665.48 |
DisclosureSEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 3 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2022 Filed Jan 14, 2022 01:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 267 | $32.18 | $8,592.06 |
DisclosureSEC source: 0001437749-22-000889 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,786 F1 · shares: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 16,666 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001437749-22-000824 · rdgdoc.xml · derivative · entry 5 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,002 Underlying: Common Stock · 16,666 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 16,666 | $30.83 | $513,812.78 |
DisclosureSEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,455 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.67 to $31.53, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 10, 2022 Filed Jan 13, 2022 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 16,666 | $1.78 | $29,665.48 |
DisclosureSEC source: 0001437749-22-000824 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,121 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 01:00 UTC |
DE GREEF RODERICKCOO & President
|
SaleCommon Stock | 567 | $30.75 | $17,435.25 |
DisclosureSEC source: 0001437749-22-000745 · rdgdoc.xml · nonDerivative · entry 3 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,812 F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 01:00 UTC |
DE GREEF RODERICKCOO & President
|
SaleCommon Stock | 2,053 | $30.75 | $63,129.75 |
DisclosureSEC source: 0001437749-22-000745 · rdgdoc.xml · nonDerivative · entry 2 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,379 F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 01:00 UTC |
DE GREEF RODERICKCOO & President
|
SaleCommon Stock | 8,196 | $30.75 | $252,027.00 |
DisclosureSEC source: 0001437749-22-000745 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,432 F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 07, 2022 Filed Jan 12, 2022 01:00 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 47 | $30.75 | $1,445.25 |
DisclosureSEC source: 0001437749-22-000744 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,075 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| January 07, 2022 Filed Feb 18, 2022 01:26 UTC Amendment |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 47 | $30.75 | $1,445.25 |
DisclosureSEC source: 0001437749-22-003761 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,075 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · acquired: On January 11, 2022, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 01:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 7,857 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001437749-22-000565 · rdgdoc.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,857 shares Expires 2022-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 15, 2012, the reporting person was granted an option to purchase 17,857 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 01:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 7,857 | $34.30 | $269,495.10 |
DisclosureSEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.10 to $35.46, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 01:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 7,857 | $1.40 | $10,999.80 |
DisclosureSEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 01:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001437749-22-000565 · rdgdoc.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,857 Underlying: Common Stock · 10,000 shares Expires 2022-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 15, 2012, the reporting person was granted an option to purchase 17,857 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 01:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 10,000 | $35.06 | $350,600.00 |
DisclosureSEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,014 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of September 7, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.59 to $35.33, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| January 04, 2022 Filed Jan 7, 2022 01:00 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $1.40 | $14,000.00 |
DisclosureSEC source: 0001437749-22-000565 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 29, 2021 Filed Dec 31, 2021 01:04 UTC |
Mathew Aby J.EVP & Chief Scientific Officer
|
SaleCommon Stock | 736 | $39.37 | $28,976.32 |
DisclosureSEC source: 0001437749-21-029534 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,014 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 29, 2021 Filed Dec 31, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 928 | $39.37 | $36,535.36 |
DisclosureSEC source: 0001437749-21-029532 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,455 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 29, 2021 Filed Dec 31, 2021 01:03 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 625 | $39.37 | $24,606.25 |
DisclosureSEC source: 0001437749-21-029533 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,820 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 29, 2021 Filed Dec 31, 2021 01:01 UTC |
DE GREEF RODERICKCOO & President
|
SaleCommon Stock | 705 | $39.37 | $27,755.85 |
DisclosureSEC source: 0001437749-21-029531 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · COO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,628 F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 29, 2021 Filed Dec 31, 2021 01:00 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 517 | $39.37 | $20,354.29 |
DisclosureSEC source: 0001437749-21-029530 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,147 F1 · kind: The sale reported herein was made by to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 22, 2021 Filed Dec 24, 2021 01:00 UTC |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 310 | $38.49 | $11,931.90 |
DisclosureSEC source: 0001437749-21-029225 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,122 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| December 22, 2021 Filed Feb 18, 2022 01:28 UTC Amendment |
Wichterman TroyChief Financial Officer
|
SaleCommon Stock | 310 | $38.49 | $11,931.90 |
DisclosureSEC source: 0001437749-22-003762 · rdgdoc.xml · nonDerivative · entry 1 Wichterman Troy · CIK 0001892616 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,122 F1 · kind: The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. F2 · acquired: On December 23, 2021, the reporting person filed a Form 4 which inadvertently reported in Column 4 of Table I that the sale to cover transaction was an acquisition of securities rather than a disposition of securities. In fact, as reported in this amendment, the reporting person disposed of those shares. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 16,666 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001437749-21-028681 · rdgdoc.xml · derivative · entry 6 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,668 Underlying: Common Stock · 16,666 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 01:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 16,666 | $32.80 | $546,644.80 |
DisclosureSEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 4 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,383 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.12 to $33.71, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 16,666 | $1.78 | $29,665.48 |
DisclosureSEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 3 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 16,666 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001437749-21-028681 · rdgdoc.xml · derivative · entry 5 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,334 Underlying: Common Stock · 16,666 shares Expires 2022-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 07, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock which vested 25% on the first anniversary of the grant date, and in 36 equal monthly installments thereafter. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:00 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 16,666 | $33.82 | $563,644.12 |
DisclosureSEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,383 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of December 1, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.98 to $34.51, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 13, 2021 Filed Dec 16, 2021 01:00 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 16,666 | $1.78 | $29,665.48 |
DisclosureSEC source: 0001437749-21-028681 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.